documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

15 rows where docket_id = "FDA-2014-D-1167" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 6

document_type 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2014-D-1167-0027 FDA None FDA-2014-D-1167 Controlled Correspondence Related to Generic Drug Development; Guidance for Industry; Availability Notice Notice of Availability 2024-03-18T04:00:00Z 2024 3     2024-03-20T12:35:59Z 2024-05687 0 0 09000064864808b5
FDA-2014-D-1167-0028 FDA None FDA-2014-D-1167 Controlled Correspondence Related to Generic Drug Development; Guidance for Industry Other Guidance 2024-03-18T04:00:00Z 2024 3 2024-03-18T04:00:00Z   2025-04-17T16:24:57Z   1 0 0900006486481276
FDA-2014-D-1167-0024 FDA None FDA-2014-D-1167 Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability Notice Notice of Availability 2022-12-22T05:00:00Z 2022 12     2022-12-22T13:50:27Z 2022-27827 0 0 090000648554d546
FDA-2014-D-1167-0025 FDA None FDA-2014-D-1167 Controlled Correspondence Related to Generic Drug Development; Guidance for Industry; Draft Guidance Other Guidance 2022-12-22T05:00:00Z 2022 12 2022-12-22T05:00:00Z 2023-02-22T04:59:59Z 2024-03-18T13:33:56Z   0 0 090000648554cff7
FDA-2014-D-1167-0022 FDA None FDA-2014-D-1167 Controlled Correspondence Related to Generic Drug Development; Guidance for Industry Other Guidance 2020-12-17T05:00:00Z 2020 12 2020-12-17T05:00:00Z   2022-12-22T13:59:06Z   0 0 09000064849a5cce
FDA-2014-D-1167-0021 FDA None FDA-2014-D-1167 Controlled Correspondence Related to Generic Drug Development; Guidance for Industry; Availability Notice Notice of Availability 2020-12-17T05:00:00Z 2020 12 2020-12-17T05:00:00Z   2020-12-17T19:19:44Z 2020-27810 0 0 09000064849a4518
FDA-2014-D-1167-0017 FDA None FDA-2014-D-1167 Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability; Correction Notice Correction 2017-11-17T05:00:00Z 2017 11 2017-11-17T05:00:00Z   2017-11-17T20:10:11Z 2017-24948 0 0 0900006482c8a43d
FDA-2014-D-1167-0016 FDA None FDA-2014-D-1167 Draft Guidance for Industry on Controlled Correspondence Related to Generic Drug Development Other Guidance 2017-11-03T04:00:00Z 2017 11 2017-11-03T04:00:00Z   2022-12-22T13:58:49Z   0 0 0900006482c3ee67
FDA-2014-D-1167-0015 FDA None FDA-2014-D-1167 Controlled Correspondence Related to Generic Drug Development; Draft Guidance for Industry; Availability Notice Notice of Availability 2017-11-03T04:00:00Z 2017 11 2017-11-03T04:00:00Z 2018-01-03T04:59:59Z 2018-01-03T02:01:35Z 2017-23947 0 0 0900006482c3e633
FDA-2014-D-1167-0014 FDA None FDA-2014-D-1167 Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Controlled Correspondence Related to Generic Drug Development Notice Notice of Approval 2015-10-30T04:00:00Z 2015 10 2015-10-30T04:00:00Z   2019-06-18T16:45:55Z 2015-27741 0 0 0900006481cfcaa7
FDA-2014-D-1167-0012 FDA None FDA-2014-D-1167 Controlled Correspondence Related to Generic Drug Development; Guidance for Industry; Availability Notice Notice of Availability 2015-09-29T04:00:00Z 2015 9 2015-09-29T04:00:00Z   2015-09-29T14:14:27Z 2015-24621 0 0 0900006481ca0e1f
FDA-2014-D-1167-0013 FDA None FDA-2014-D-1167 Controlled Correspondence Related to Generic Drug Development Guidance for Industry Other Guidance 2015-09-29T04:00:00Z 2015 9 2015-09-29T04:00:00Z   2019-06-18T16:45:38Z   0 0 0900006481ca1ef1
FDA-2014-D-1167-0003 FDA None FDA-2014-D-1167 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Controlled Correspondence Related to Generic Drug Development Notice 30 Day Proposed Information Collection 2015-07-02T04:00:00Z 2015 7 2015-07-02T04:00:00Z 2015-08-04T03:59:59Z 2015-08-04T01:30:57Z 2015-16358 0 0 0900006481b670a4
FDA-2014-D-1167-0002 FDA None FDA-2014-D-1167 Draft Guidance for Industry on Controlled Correspondence Related to Generic Drug Development Other Guidance 2014-08-27T04:00:00Z 2014 8 2014-08-27T04:00:00Z   2019-06-18T16:45:19Z   0 0 09000064818483c9
FDA-2014-D-1167-0001 FDA None FDA-2014-D-1167 Draft Guidance for Industry on Controlled Correspondence Related to Generic Drug Development; Availability Notice Notice of Availability 2014-08-27T04:00:00Z 2014 8 2014-08-27T04:00:00Z 2014-10-28T03:59:59Z 2015-09-12T01:31:10Z 2014-20359 0 0 0900006481847bfd

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;